FDA Inspection 841845 — Baxter R & D Europe
The FDA completed an inspection of Baxter R & D Europe on Jun 21, 2013 in Braine-L'Alleud. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 21, 2013
- Fiscal Year
- 2013
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Braine-L'Alleud (Belgium)